Found: 19
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 5, p. 869, doi. 10.1111/bjh.16980
- By:
- Publication type:
- Article
Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 860, doi. 10.1111/bjh.16446
- By:
- Publication type:
- Article
Phase 1–2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. e7, doi. 10.1111/bjh.15847
- By:
- Publication type:
- Article
Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and Recommendations.
- Published in:
- AAPS Journal, 2018, v. 20, n. 3, p. 1, doi. 10.1208/s12248-018-0204-y
- By:
- Publication type:
- Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
- By:
- Publication type:
- Article
Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 6, p. 1591, doi. 10.1111/bcp.13092
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 2, p. 127, doi. 10.1007/s40261-015-0357-8
- By:
- Publication type:
- Article
Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e16, doi. 10.1016/j.clml.2019.09.023
- By:
- Publication type:
- Article
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 902, doi. 10.1002/cpt.3350
- By:
- Publication type:
- Article
Response of authors to Ganju and Dias' comments on 'Inclusion of Placebos and Blinding for Ascending Dose First-in-Human Studies and Other Underpowered Phase 1 Studies Has Not Been Justified and on Balance is Not Useful' by D. A. Parasrampuria and L. Z. Benet.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Inclusion of Placebos and Blinding for Ascending Dose First-in-Human Studies and Other Underpowered Phase 1 Studies has not been Justified and on Balance is Not Useful.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2015, v. 117, n. 1, p. 44, doi. 10.1111/bcpt.12352
- By:
- Publication type:
- Article
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1286, doi. 10.1002/jcph.540
- By:
- Publication type:
- Article
Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 12, p. 1476, doi. 10.1177/0091270007308615
- By:
- Publication type:
- Article
Single-Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen-Activated Protein Kinase Inhibitor: A First-in-Human Study.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 4, p. 406
- By:
- Publication type:
- Article
Effect of Calcineurin Inhibitor Therapy on P-gp Expression and Function in Lymphocytes of Renal Transplant Patients: A Preliminary Evaluation.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 3, p. 304, doi. 10.1177/009127000204200307
- By:
- Publication type:
- Article
Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 614, doi. 10.1002/jcph.1771
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Decitabine in Pediatric Patients With Acute Myeloid Leukemia.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 668, doi. 10.1002/jcph.1357
- By:
- Publication type:
- Article
Single-Dose Pharmacokinetics and Metabolism of the Oral Decongestant Phenylephrine HCl in Children and Adolescents.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 1, p. 139, doi. 10.1007/s41030-022-00206-8
- By:
- Publication type:
- Article